ISEC Healthcare forms joint venture to build ophthalmology centre in Johor

SGX Filings

Dec 31, 2025

ISEC Healthcare said on Dec, 31 2025 that its wholly-owned subsidiary, ISEC Sdn. Bhd., has signed a joint-venture agreement with Bond Infinity, K.C. Yeo Eye Specialist Clinic and Wedjat Vision to incorporate ISEC (Batu Pahat) Sdn. Bhd. in Malaysia.

The new company will establish, operate and manage an ophthalmology centre in Batu Pahat, Johor. Initial issued capital will be 110 Malaysian ringgit shares, rising to RM1,064,890—about 0.34 million Singapore dollars—within nine months through new share subscriptions.

After the capital increase, ISEC Sdn. Bhd. will own 71.83% of the joint venture, which will be treated as an indirect subsidiary of ISEC Healthcare.

ISEC Healthcare will finance its contribution from internal resources. The firm said the transaction is classified as a non-discloseable event under Catalist Rule 1006 and will not materially affect its net tangible assets or earnings per share for the year ending Dec, 31 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1119313168"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1119313168\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1119313168?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-31 20:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1119313168","market":"sg","top_or_hot":-1,"title":"ISEC Healthcare forms joint venture to build ophthalmology centre in Johor","media":"SGX Filings","content":"<p>ISEC Healthcare said on Dec, 31 2025 that its wholly-owned subsidiary, ISEC Sdn. Bhd., has signed a joint-venture agreement with Bond Infinity, K.C. Yeo Eye Specialist Clinic and Wedjat Vision to incorporate ISEC (Batu Pahat) Sdn. Bhd. in Malaysia.</p>\n<p>The new company will establish, operate and manage an ophthalmology centre in Batu Pahat, Johor. Initial issued capital will be 110 Malaysian ringgit shares, rising to RM1,064,890—about 0.34 million Singapore dollars—within nine months through new share subscriptions.</p>\n<p>After the capital increase, ISEC Sdn. Bhd. will own 71.83% of the joint venture, which will be treated as an indirect subsidiary of ISEC Healthcare.</p>\n<p>ISEC Healthcare will finance its contribution from internal resources. The firm said the transaction is classified as a non-discloseable event under Catalist Rule 1006 and will not materially affect its net tangible assets or earnings per share for the year ending Dec, 31 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ISEC Healthcare forms joint venture to build ophthalmology centre in Johor</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nISEC Healthcare forms joint venture to build ophthalmology centre in Johor\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1083912268\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">SGX Filings </p>\n<p class=\"h-time\">2025-12-31 20:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>ISEC Healthcare said on Dec, 31 2025 that its wholly-owned subsidiary, ISEC Sdn. Bhd., has signed a joint-venture agreement with Bond Infinity, K.C. Yeo Eye Specialist Clinic and Wedjat Vision to incorporate ISEC (Batu Pahat) Sdn. Bhd. in Malaysia.</p>\n<p>The new company will establish, operate and manage an ophthalmology centre in Batu Pahat, Johor. Initial issued capital will be 110 Malaysian ringgit shares, rising to RM1,064,890—about 0.34 million Singapore dollars—within nine months through new share subscriptions.</p>\n<p>After the capital increase, ISEC Sdn. Bhd. will own 71.83% of the joint venture, which will be treated as an indirect subsidiary of ISEC Healthcare.</p>\n<p>ISEC Healthcare will finance its contribution from internal resources. The firm said the transaction is classified as a non-discloseable event under Catalist Rule 1006 and will not materially affect its net tangible assets or earnings per share for the year ending Dec, 31 2025.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"40T.SI","symbol_name":"国际眼科中心","start_time":0,"source_url":"","article_id":"1119313168","we_media_id":"1083912268","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1119313168","pubTimestamp":1767182879,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"SGX Filings","introduction":"Fastest News on SGX Filings ","home_visible":1,"id":"1083912268","head_image":"https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39"},"summary":"ISEC Healthcare said on Dec, 31 2025 that its wholly-owned subsidiary, ISEC Sdn. Bhd., has signed a joint-venture agreement with Bond Infinity, K.C. Yeo Eye Specialist Clinic and Wedjat Vision to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"40T.SI":"国际眼科中心"},"translate_title":"ISEC Healthcare成立合资企业在柔佛州建设眼科中心","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"40T.SI":1},"content_text":"ISEC Healthcare said on Dec, 31 2025 that its wholly-owned subsidiary, ISEC Sdn. Bhd., has signed a joint-venture agreement with Bond Infinity, K.C. Yeo Eye Specialist Clinic and Wedjat Vision to incorporate ISEC (Batu Pahat) Sdn. Bhd. in Malaysia.\nThe new company will establish, operate and manage an ophthalmology centre in Batu Pahat, Johor. Initial issued capital will be 110 Malaysian ringgit shares, rising to RM1,064,890—about 0.34 million Singapore dollars—within nine months through new share subscriptions.\nAfter the capital increase, ISEC Sdn. Bhd. will own 71.83% of the joint venture, which will be treated as an indirect subsidiary of ISEC Healthcare.\nISEC Healthcare will finance its contribution from internal resources. The firm said the transaction is classified as a non-discloseable event under Catalist Rule 1006 and will not materially affect its net tangible assets or earnings per share for the year ending Dec, 31 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"corporation,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}